v3.26.3
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders
 9 Months Ended
Sep. 27, 2026
Earnings Per Share [Abstract]  
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders
The following presents the detailed calculation of EPS:
Three Months EndedNine Months Ended
(MILLIONS)September 27,
2026		September 28,
2025		September 27,
2026		September 28,
2025
EPS Numerator
Income from continuing operations attributable to Pfizer Inc. common shareholders$3,241 $3,541 $5,686 $9,393 
Discontinued operations––net of tax— — (5)25 
Net income attributable to Pfizer Inc. common shareholders$3,242 $3,541 $5,681 $9,419 
EPS Denominator
Weighted-average number of common shares outstanding––Basic5,700 5,685 5,697 5,682 
Common-share equivalents52 29 42 29 
Weighted-average number of common shares outstanding––Diluted5,751 5,714 5,739 5,710 
Anti-dilutive common stock equivalents(a)
10 8 11 11 
(a)These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.